Wird geladen...
The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus
BACKGROUND: Sodium glucose co‐transporter 2 (SGLT2) inhibitors are a new class of pharmacologic agents developed for the treatment of type 2 diabetes mellitus (T2DM). Their unique mechanism of action is independent of pancreatic beta‐cell function or the degree of insulin resistance, giving these ag...
Gespeichert in:
| Veröffentlicht in: | Int J Clin Pract |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758393/ https://ncbi.nlm.nih.gov/pubmed/26147213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12675 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|